Results 1 to 10 of about 2,642,573 (281)

mGem: Immune recognition and clearance of bacteriophages-implications for phage therapy. [PDF]

mBio
Le HT, Ahlenstiel G, Venturini C, Read SA.   +3 more
europepmc   +1 more source

Phage therapy in revision arthroplasty: State of the art and application protocols. [PDF]

Arthroplasty
Wolfgart JM, Schenker H, Gatz M, Migliorini F, Eschweiler J, Langwald S, Horz HP, Eisert A, Schwanz T, Hofmann UK.   +9 more
europepmc   +1 more source

Phages and quorum sensing: findings to consider in phage therapy. [PDF]

Eur J Clin Microbiol Infect Dis
Fernández-Garcia L, Blasco L, Bleriot I, Arman L, Ibarguren-Quiles C, Barrio-Pujante A, de Aledo MG, García-Contreras R, Cantón R, Wood TK, Tomas M.   +10 more
europepmc   +1 more source

Molecular diversity and evolutionary dynamics of phage receptor binding proteins in Staphylococcus aureus: implications for phage therapy and resistance. [PDF]

Sci Rep
VinodKumar CS, Prasad BS, Arunkumar A, Najar IN, Singh A, Emilda JKV, Venkatesh R, Sivaji V, Jayasimha VL, Arakera SB, Kalasuramath S, Ramesh N, Veeraraghavan B.   +12 more
europepmc   +1 more source

Phage therapy for environmental biotechnology applications. [PDF]

Front Microbiol
Singh S, Samson R, Hassard F.
europepmc   +1 more source

Steering the course: targeting and exploiting surface receptors in phage therapy. [PDF]

J Bacteriol
Tran VN, Burrows LL.
europepmc   +1 more source

Pharmacodynamic individualization of phage therapy against a KPC-5-producing Pseudomonas aeruginosa. [PDF]

JAC Antimicrob Resist
Nguyen TD, Sanborn JT, Ho BM, Luong T, Wood TD, Chen L, Roach DR, Smith NM.   +7 more
europepmc   +1 more source

Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance. [PDF]

Front Antibiot
Topa-Pila P, Morales KY, Palacios-Mora DP, Flores-Hernández C, Altamirano-Cisneros A, Gavilanes JM, Villacís-López K, Arancibia M, Mora-Domínguez J, Calero-Cáceres W.   +9 more
europepmc   +1 more source

Phage therapy and the microbiome in hematologic malignancies: opportunities, mechanisms, and early evidence.

J Cancer Res Clin Oncol
Zhang J, Liu J, Bayani A.
europepmc   +1 more source